TCWM
AXSM icon

Total Clarity Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Total Clarity Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-221
Closed -$7K – 981
2021
Q3 		$7K Buy
+221
New +$8.61K ﹤0.01% 744
2021
Q2 		– Sell
-727
Closed -$41K – 234
2021
Q1 		$41K Buy
+727
New +$51.1K 0.02% 367
2020
Q1 		– Sell
-245
Closed -$25K – 127
2019
Q4 		$25K Buy
+245
New +$9.89K 0.02% 358

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Total Clarity Wealth Management's AXSM Position: Q4 2021 in Review

Total Clarity Wealth Management sold out of Axsome Therapeutics (AXSM) in Q4 2021, closing a stake of 221 shares — an estimated $7K sold.

Total Clarity Wealth Management first reported a position in AXSM in Q4 2019 and held it in 3 quarters. The position peaked at $41K in Q1 2021. 167 funds tracked by Wall St. Rank hold AXSM as of Q4 2021.

  • Total Clarity Wealth Management reported no remaining Axsome Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Total Clarity Wealth Management sold 221 Axsome Therapeutics shares in Q4 2021, an estimated $7K.
  • Total Clarity Wealth Management first reported a position in Axsome Therapeutics in Q4 2019 and held it in 3 quarters.
  • Total Clarity Wealth Management's Axsome Therapeutics position peaked at $41K in Q1 2021.
  • 167 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2021.

Based on Total Clarity Wealth Management's 13F filing for Q4 2021, filed 3 Feb 2022.